Page 3 - Dose Level News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMonzrm al malkiHeather savelleDebora bartonGavin macbeathAl malkiJoyce allaireDepartment of hematology hematopoietic cell transplantationGlobe newswire tscan therapeutics incLifesci advisorsAmerican society of hematology annual meetingTscan therapeutics incAmerican society of hematologySecurities exchangeTherapeutics presents initial phaseAmerican society

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoMaghan meyersKrish patelBrent pfeiffenbergerMelissa forstAmerican society of hematologyCentury therapeutics incInternational numberLymphoma programSwedish cancer instituteDrug administrationExchange commissionGlobenewswire incDose levelAnnual meeting

Century Therapeutics Presents Initial Data from CNTY-101

Century Therapeutics Presents Initial Data from CNTY-101
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesBrent pfeiffenbergerKrish patelSwedish cancer instituteInternational numberDrug administrationAmerican society of hematologyExchange commissionLymphoma programDose levelAmerican societyAnnual meetingDerived allogeneicTumor microenvironment changes associatedScientific resources

Anixa Bio stock falls after data for breast cancer vaccine

Anixa Bio stock falls after data for breast cancer vaccine
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Us department of defenseCleveland clinicDose level

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,.

United statesSan antonioMike catelaniAnixa biosciencesStephen kilmerAmit kumarG thomas buddVincent tuohyCleveland clinic lerner research instituteUs department of defenseInnovative breast cancer researchCleveland clinic cancer instituteDepartment of inflammationMoffitt cancer centerAnixa biosciences incCleveland clinic